SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : T.ITE: iTech Capital (TSE) -- Ignore unavailable to you. Want to Upgrade?


To: Claude Cormier who wrote (4233)2/24/2000 4:09:00 PM
From: ROb  Read Replies (1) | Respond to of 5053
 
Message 12957161



To: Claude Cormier who wrote (4233)2/24/2000 8:26:00 PM
From: Condor  Read Replies (2) | Respond to of 5053
 
Claude, this issue of share ownership comes up as speculation often so I called Jim Graham at JDX/ITE at 5:00 pm. and put it to him. He said that we own a total of 222,000 shares of medsite.com. The extra 22,000 shares were an additional purchase we made to keep our ownership at a constant level. The shares are convertible 1 for 1. That being the case, we now know we paid $ 5 per share by simple arithmetic comparing our investment vs. the shares we own. So this begs the question: What will these shares be worth after the IPO?
Rob Davis in his post layed it out quite well. No one knows until the IPO issues and trades in about 6-8 weeks? Let's try to do some logical speculation and see if we can come up with a number that might be reasonable.
I went back and checked Neoformas (NEOF) IPO of about 5 weeks ago to see what happened there.
siliconinvestor.com
They sell to the medical institutions larger medical items so are VERY roughly in Medsites field. They IPO'd at $ 13 and proceeded on up to $78 and have settled to $ 58 recently. They now have a market cap of 3 1/4 billion. Now, are you ready for this......when they IPO'd they had revenue (not earnings)of $ 464,000 per year. Yes, $ 464,000....sheesh.
So, lets look at Medsite.com, revenues of $ 8,900,000 in 1999 and a much broader product base than NEOF. It does not seem unreasonable to assume that if Medsite IPOs at $ 13 that they could trade from a dismal number say $ 25 to a satisfactory number, say $ 100. Given that their underwriters are Credit Suisse Boston, Bear, Stearns and Co and E*Offering I'd be inclined to think the high end is conservatively probable. However for the sake of argument lets look at the range. (being $ 25 and $ 100 )This means that the offering if it only achieves $ 25 then our $5 per share becomes $25 per share OR if the offering achieves $ 100 then our $5 per share becomes $ 100 per share. This range gives us potential multiples of 400% to % 1900 on our investment or in absolute dollars PROFIT of from $4,440,000 to $ 21,090,000. Not bad for a 7 month investment of $1,110,000.
So when the Medsite IPO begins to trade, take the per share price and deduct $ 5 and multiply times 222,000 and thats JDX/ITE net profit position.
I wonder what that sexy "Elastic Networks" would do?
Claude, I know these were baby steps for you in the above exercise but I just wanted to make it very clear for everyone, particularily for myself. <g>
OT: P.S. Claude, I would appreciate your giving me your thoughts on FL by PM or on the FL thread.
Regards
C